Literature DB >> 25275939

Visceral mesh modified with cyclodextrin for the local sustained delivery of ropivacaine.

G Vermet1, S Degoutin2, F Chai3, M Maton3, M Bria4, C Danel5, H F Hildebrand3, N Blanchemain3, B Martel6.   

Abstract

The aim of the study was to develop a polyester visceral implant modified with a cyclodextrin polymer for the local and prolonged delivery of ropivacaine to reduce post operatory pain. Therefore, we applied a coating of an inguinal mesh with a crosslinked polymer of hydroxypropyl-β-cyclodextrin (HPβCD) whose specific host-guest complex forming properties were expected to improve the adsorption capacity of the implant toward anesthetic, and then to release it within a sustained period. The modification reaction of the textile with cyclodextrin was explored through the study of the influence of the pad/dry/cure process parameters and the resulting implant (PET-CD) was characterized by solid state NMR and SEM. Besides, the inclusion complex between ropivacaine and CD was studied by NMR and capillary electrophoresis in PBS medium. Finally, ropivacaine sorption test showed that a maximum of 30 mg/g of ropivacaine could be adsorbed on the functionalized samples. In dynamic batch tests in PBS at pH 7.4, the release could be observed up to 6h. The cytocompatibility of the PET-CD loaded with ropivacaine was also studied and reached 65% cell vitality after 6 days.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cyclodextrin; Local anesthetic; Prolonged delivery; Ropivacaine; Surface modification; Visceral mesh textile

Mesh:

Substances:

Year:  2014        PMID: 25275939     DOI: 10.1016/j.ijpharm.2014.09.042

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

Review 1.  Emerging technologies for long-term antimicrobial device coatings: advantages and limitations.

Authors:  Erika L Cyphert; Horst A von Recum
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

2.  Injectable nanocomposite analgesic delivery system for musculoskeletal pain management.

Authors:  Manakamana Khanal; Shalini V Gohil; Emmanuel Kuyinu; Ho-Man Kan; Brittany E Knight; Kyle M Baumbauer; Kevin W-H Lo; Joseph Walker; Cato T Laurencin; Lakshmi S Nair
Journal:  Acta Biomater       Date:  2018-05-25       Impact factor: 8.947

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.